Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (CN102292124) Methods for treating acute myocardial infarctions and associated disorders

Office : China
Application Number: 201080005590.7 Application Date: 26.01.2010
Publication Number: 102292124 Publication Date: 21.12.2011
Publication Kind : A
Prior PCT appl.: Application Number:PCTUS2010022112 ; Publication Number:2010085805 Click to see the data
IPC:
A61P 9/10
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9
Drugs for disorders of the cardiovascular system
10
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
CPC:
A61K 31/415
A61K 31/00
A61K 31/4365
A61K 31/437
A61K 31/4418
A61K 31/4433
A61K 31/4436
A61K 31/4439
A61K 31/444
A61K 31/496
A61K 31/4965
A61K 31/50
A61K 31/506
A61K 31/513
A61K 31/53
A61K 31/5377
A61K 31/706
Applicants: Intermune Inc
英特芒尼公司
Univ California
加州大学评议会
Inventors: Olgin Jeff
J·奥尔金
Kossen Karl
K·科森
Agents: ma chongde guo wenji
中国专利代理(香港)有限公司 72001
中国专利代理(香港)有限公司 72001
Priority Data: 61/147340 26.01.2009 US
Title: (EN) Methods for treating acute myocardial infarctions and associated disorders
(ZH) 用于治疗急性心肌梗死和相关疾患的方法
Abstract: front page image
(EN) The invention relates to methods of treating patients who have suffered an acute myocardial infarction (AMI) with a therapeutic that has anti-fibrotic effects, for example, pirfenidone and analogs thereof The method of treating a patient who has suffered an acute myocardial infarction may include administering to the patient a therapeutically effective dose of a therapeutic having an anti-fibrotic effect, wherein optionally the treatment is initiated at a time period about 1 to 42 days after suffering the AMI, and optionally continues for up to 3 to 6 months.
(ZH)

本发明涉及用具有抗纤维化作用的治疗剂例如甲苯吡啶酮及其类似物来治疗罹患急性心肌梗死(AMI)的患者的方法。治疗罹患急性心肌梗死的患者的方法可包括给患者施用治疗有效剂量的具有抗纤维化作用的治疗剂,其中任选地治疗在罹患AMI后约1至42天的时间段开始,并且任选地持续最多3至6个月。


Also published as:
NZ593583UAa201109441IL213526MXMX/a/2011/007854SG172981EP2389227
JP2012515800CA2747251MX2011007854KR1020110114684TN2011000364BRPI1006979
AU2010206543ID2012/00475MYPI 2011003334IN5985/DELNP/2011WO/2010/085805